This document is an excerpt from the EUR-Lex website
Document 02026R0355-20260219
Commission Implementing Regulation (EU) 2026/355 of 18 February 2026 renewing the approval of the active substance pyrimethanil in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) No 540/2011 (Text with EEA relevance)
Consolidated text: Commission Implementing Regulation (EU) 2026/355 of 18 February 2026 renewing the approval of the active substance pyrimethanil in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) No 540/2011 (Text with EEA relevance)
Commission Implementing Regulation (EU) 2026/355 of 18 February 2026 renewing the approval of the active substance pyrimethanil in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) No 540/2011 (Text with EEA relevance)
02026R0355 — EN — 19.02.2026 — 000.001
This text is meant purely as a documentation tool and has no legal effect. The Union's institutions do not assume any liability for its contents. The authentic versions of the relevant acts, including their preambles, are those published in the Official Journal of the European Union and available in EUR-Lex. Those official texts are directly accessible through the links embedded in this document
|
COMMISSION IMPLEMENTING REGULATION (EU) 2026/355 of 18 February 2026 renewing the approval of the active substance pyrimethanil in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) No 540/2011 (OJ L 355 19.2.2026, p. 1) |
Corrected by:
|
Corrigendum, OJ L 90340, 30.4.2026, p. 1 ((EU) 2026/3552026/355) |
COMMISSION IMPLEMENTING REGULATION (EU) 2026/355
of 18 February 2026
renewing the approval of the active substance pyrimethanil in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) No 540/2011
(Text with EEA relevance)
Article 1
Renewal of the approval of the active substance
The approval of the active substance pyrimethanil, as specified in Annex I to this Regulation, is renewed, subject to the conditions laid down in that Annex.
Article 2
Amendments to Implementing Regulation (EU) No 540/2011
The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with Annex II to this Regulation.
This Regulation shall be binding in its entirety and directly applicable in all Member States.
ANNEX I
|
Common Name, Identification Numbers |
IUPAC Name |
Purity (1) |
Date of approval |
Expiration of approval |
Specific provisions |
|
Pyrimethanil CAS No: 53112-28-0 CIPAC No: 714 |
N-(4,6-dimethylpyrimidin-2-yl) aniline |
≥ 975 g/kg The following impurities shall not exceed the following levels in the technical material: — cyanamide: 0,5 g/kg; — aniline: 4 g/kg; — acetylacetone: 0,1 g/kg. |
1 May 2026 |
30 April 2041 |
For the implementation of the uniform principles as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the renewal report on pyrimethanil, and in particular Appendices I and II thereto, shall be taken into account. In this overall assessment Member States shall pay particular attention to: — the protection of operators, ensuring that conditions of use include the application of adequate personal protective equipment; — the protection of bystanders and residents, ensuring that drift reduction measures are applied, where necessary; — the protection of aquatic organisms, bees and other pollinators. Conditions of use shall include risk mitigation measures, where appropriate. The applicant shall submit confirmatory information as regards: (1) the toxicity of the metabolite M605F004, including its conjugates, and the metabolite M605F007, to confirm the relevant residue definitions for risk assessment; (2) the effect of water treatment processes on the residues of pyrimethanil or its metabolites present in water abstracted for the production of drinking water, in accordance with the EFSA and ECHA Guidance document on the impact of water treatment processes on residues of active substances or their metabolites in water abstracted for the production of drinking water; (3) the degradation of pyrimethanil in soil, including where relevant the identification and characterisation of metabolites. If the information indicates the relevance of the metabolite U2, soil, surface water, sediment and groundwater exposure and risk assessment for the metabolite U2 shall be provided. The applicant shall submit to the Commission, the Member States and the Authority the information referred to in points 1.2 and 3 by 11 March 2028. |
|
(1)
Further details on the identity and specification of the active substance are provided in the renewal report. |
|||||
ANNEX II
The Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:
in Part A, entry 135 on pyrimethanil is deleted;
in Part B, the following entry is added:
|
No |
Common Name, Identification Numbers |
IUPAC Name |
Purity (1) |
Date of approval |
Expiration of approval |
Specific provisions |
|
‘179 |
Pyrimethanil CAS No: 53112-28-0 CIPAC No: 714 |
N-(4,6-dimethylpyrimidin-2-yl) aniline |
≥ 975 g/kg The following impurities shall not exceed the following levels in the technical material: — cyanamide: 0,5 g/kg; — aniline: 4 g/kg; — acetylacetone: 0,1 g/kg. |
1 May 2026 |
30 April 2041 |
For the implementation of the uniform principles as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the renewal report on pyrimethanil, and in particular Appendices I and II thereto, shall be taken into account. In this overall assessment Member States shall pay particular attention to: — the protection of operators, ensuring that conditions of use include the application of adequate personal protective equipment; — the protection of bystanders and residents, ensuring that drift reduction measures are applied, where necessary; — the protection of aquatic organisms, bees and other pollinators. Conditions of use shall include risk mitigation measures, where appropriate. The applicant shall submit confirmatory information as regards: (1) the toxicity of the metabolite M605F004, including its conjugates, and the metabolite M605F007, to confirm the relevant residue definitions for risk assessment; (2) the effect of water treatment processes on the residues of pyrimethanil or its metabolites present in water abstracted for the production of drinking water, in accordance with the EFSA and ECHA Guidance document on the impact of water treatment processes on residues of active substances or their metabolites in water abstracted for the production of drinking water; (3) the degradation of pyrimethanil in soil, including where relevant the identification and characterisation of metabolites. If the information indicates the relevance of the metabolite U2, soil, surface water, sediment and groundwater exposure and risk assessment for the metabolite U2 shall be provided. The applicant shall submit to the Commission, the Member States and the Authority the information referred to in points 1.2 and 3 by 11 March 2028.’ |
|
(1)
Further details on the identity and specification of the active substance are provided in the renewal report. |
||||||